Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
Breakpoints - #4 – How ECCMID 2019 went viral

#4 – How ECCMID 2019 went viral

Breakpoints

07/10/19 • 31 min

plus icon
Not bookmarked icon
Share icon

Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review results of ASPECT-NP (Ceftolozane-tazobactam versus meropenem in patients with ventilated nosocomial pneumonia), CAMERA-2 (Combination therapy for methicillin-resistant Staphylococcus aureus bacteraemia), and Exebacase for patients with methicillin-resistant Staphylococcus aureus bacteraemia (Phase 2).

Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/

07/10/19 • 31 min

plus icon
Not bookmarked icon
Share icon

Episode Comments

0.0

out of 5

Star filled grey IconStar filled grey IconStar filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey Icon
Star filled grey Icon

No ratings yet

Star iconStar iconStar iconStar iconStar icon

eg., What part of this podcast did you like? Ask a question to the host or other listeners...

Post

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/breakpoints-474/4-how-eccmid-2019-went-viral-55218"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to #4 – how eccmid 2019 went viral on goodpods" style="width: 225px" /> </a>

Copy